Complete regression of esophageal cancer with concomitant liver metastasis achieved by concurrent chemoradiation therapy

International Journal of Clinical Oncology

Volumn 7, Issue 3, 2002, Pages 192-196

  Nakada, Tetsuya ^a   Nagayama, Kazuo ^a   Hiramoto, Jun ^a   Tsuruta, Yumi ^b   Murakami, Shigeto ^b   Sakabe, Shunichi ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 Fluorouracil; Chemoradiation; Cisplatin; Esophageal cancer; Liver metastasis

Indexed keywords

CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; DOSE RESPONSE; ESOPHAGUS CANCER; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; ESOPHAGUS TUMOR; LIVER TUMOR; METASTASIS; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOGRAPHY; RADIOTHERAPY; REMISSION; SQUAMOUS CELL CARCINOMA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CASE REPORT; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMAN; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; RADIOTHERAPY; REMISSION INDUCTION; TOMOGRAPHY, X-RAY COMPUTED; HUMANS;

EID: 0035985906     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101470200028     Document Type: Article

References (19)

1. Nonsurgical management of esophageal cancer: Report of a study of combined radiotherapy and chemotherapy
2. Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma
3. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
4. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study
5. Toxicity grading criteria of the Japan Clinical Oncology Group
6. Time-trends in cancer incidence and mortality in Japan
7. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma
8. Autopsy findings in 111 cases of esophageal cancer
9. Autopsy findings in squamous-cell carcinoma of the esophagus
10. Evaluation of the new (1987) TNM classification for thoracic esophageal tumors
11. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells
12. Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo
13. Current status of low-dose CDDP · 5-FU therapy for solid malignant tumors-nationwide questionnaire survey
14. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer
15. Cisplatin administered as a continuous 5-day infusion: Plasma platinum levels and urine platinum excretion
16. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and x rays
17. Interaction of platinum drugs with clinically relevant x-ray doses in mammalian cells: A comparison of cisplatin, carboplatin, iproplatin, and tetraplatin